Leveraging leptin for type I diabetes?
Kraus
Daniel
D
Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.
Herman
Mark A
MA
Kahn
Barbara B
BB
D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000172:deficiency / Q000627:therapeutic use; D020738:Leptin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D055442:Metabolome; D051379:Mice
D007328:Insulin; D020738:Leptin; D005947:Glucose